Rubric Capital Management (New York)’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.5M | Hold |
|
|||||
|
2025
Q1 | $34.4M | Hold |
|
|||||
|
2024
Q4 | $53.6M | Hold |
|
|||||
|
2024
Q3 | $62.9M | Hold |
|
|||||
|
2024
Q2 | $55.1M | Buy |
|
|||||
|
2024
Q1 | $44.7M | Hold |
|
|||||
|
2023
Q4 | $31.3M | Buy |
|
|||||
|
2023
Q3 | $15M | Hold |
|
|||||
|
2023
Q2 | $15.3M | Buy |
|
|||||
|
2023
Q1 | $7.33M | Hold |
|
|||||
|
2022
Q4 | $7.77M | Hold |
|
|||||
|
2022
Q3 | $8.93M | Sell |
|
|||||
|
2022
Q2 | $18.8M | Buy |
|
|||||
|
2022
Q1 | $16.8M | Buy |
|
|||||
|
2021
Q4 | $23.9M | Buy |
|
|||||
|
2021
Q3 | $27.3M | Buy |
|
|||||
|
2021
Q2 | $17.9M | Buy |
|
|||||
|
2021
Q1 | $9.82M | Buy |
|
|||||
|
2020
Q4 | $6.63M | Buy |
|